Skip to main content

Life Saving Drugs Program (LSDP) Laronidase (Aldurazyme) Evaluation

Project Member(s): Goodall, S., De Abreu Lourenco, R., Lewandowska, M., Addo, R.

Funding or Partner Organisation: Commonwealth Department of Health (Commonwealth Department of Health and Aged Care: C)
Commonwealth Department of Health (Commonwealth Department of Health and Aged Care: C)

Start year: 2020

Summary: This evaluation involves systematic literature reviews to address the questions in the review protocol. This will need to consider what was presented to the PBAC (and any update since then), analysis of LSDP clinical data and dispensing data, and development of a simple cost per Life Year Gained (LYG) economic model using the LSDP data (or amendment of the economic model seen by PBAC, if appropriate).

FOR Codes: Health Economics, Evaluation of Health Outcomes